CABERGOLINE
NDC 27808-315, CABERGOLINE, tablet, from Cranbury Pharmaceuticals, LLC.
- Product NDC
- 27808-315
- Status
- Listed
- Labeler
- Cranbury Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220309
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/27808-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABERGOLINE.5 mg/1
Pharmacologic classes
Ergolines [CS]; Ergot Derivative [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 27808-315-01 | 27808031501 | 8 TABLET in 1 BOTTLE (27808-315-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8562f94f-a59a-4893-aefc-ea6547b01e92
Use it
Look up 27808-315 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/27808-315 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 27808-315. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.